Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR
Open Access
- 31 March 2010
- journal article
- research article
- Published by Elsevier BV in The Journal of Molecular Diagnostics
- Vol. 12 (2), 169-176
- https://doi.org/10.2353/jmoldx.2010.090140
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumorsOncogene, 2009
- Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non–Small-Cell Lung CancerClinical Cancer Research, 2009
- EGFR Mutations in Lung Adenocarcinomas: Clinical Testing Experience and Relationship to EGFR Gene Copy Number and Immunohistochemical ExpressionThe Journal of Molecular Diagnostics, 2008
- Lung adenocarcinoma: guiding EGFR-targeted therapy and beyondLaboratory Investigation, 2008
- Epidermal Growth Factor Receptor (EGFR) High Gene Copy Number and Activating Mutations in Lung Adenocarcinomas Are Not Consistently Accompanied by Positivity for EGFR Protein by Standard ImmunohistochemistryThe Journal of Molecular Diagnostics, 2008
- Epidermal Growth Factor Receptor Mutation Testing in Lung Cancer: Searching for the Ideal MethodClinical Cancer Research, 2007
- Epidermal growth factor receptor mutations in lung cancerNature Reviews Cancer, 2007
- Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lungCancer, 2006
- Detection ofEGFRGene Mutation in Lung Cancer by Mutant-Enriched Polymerase Chain Reaction AssayClinical Cancer Research, 2006
- Rapid Polymerase Chain Reaction-Based Detection of Epidermal Growth Factor Receptor Gene Mutations in Lung AdenocarcinomasThe Journal of Molecular Diagnostics, 2005